ICAMUN BIOTHERAPEUTICS
LIVE

Serial Number

79352690

Owner

Suzhou Aikailiyuan Biotech Ltd.

Attorney

Michael T. Smith

Filing Date

Jun 2, 2022

Add to watchlist:

No watchlists yet
View on USPTO

ICAMUN BIOTHERAPEUTICS Trademark

Serial Number: 79352690 • Registration: 7318237

ICAMUN BIOTHERAPEUTICS is a trademark filed by Suzhou Aikailiyuan Biotech Ltd. on June 2, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Suzhou Aikailiyuan Biotech Ltd. (2 trademarks)

Unit E495, 5th Floor, Lecheng Plaza
Jiangsu Free Trade Zone 215127 , CN

Entity Type: 99

Trademark Details

Filing Date

June 2, 2022

Registration Date

March 5, 2024

Published for Opposition

December 19, 2023

Filing History

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 6, 2024 FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 6, 2024 FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 6, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Mar 5, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Mar 5, 2024 R.PR
NOTIFICATION PROCESSED BY IB
Dec 19, 2023 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 19, 2023 NPUB
PUBLISHED FOR OPPOSITION
Dec 19, 2023 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 29, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Nov 29, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 29, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 9, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 8, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 8, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 8, 2023 TROA
REFUSAL PROCESSED BY IB
May 31, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 10, 2023 RFCS
REFUSAL PROCESSED BY MPU
May 10, 2023 RFRR
NEW REPRESENTATIVE AT IB RECEIVED
Mar 25, 2023 NREP
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 21, 2023 RFCR
PRIORITY ACTION WRITTEN
Mar 20, 2023 CPRA
ASSIGNED TO EXAMINER
Mar 20, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Oct 21, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 17, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 13, 2022 REPR